CDC Adds Merck Cancer Vaccine to Healthcare Program
Posted on: Thursday, 2 November 2006, 12:01 CST
The Centers for Disease Control and Prevention has added Merck & Co's cervical cancer vaccine Gardasil to the Vaccines for Children contract for those who are covered under Medicaid.
Merck said that inclusion of the vaccine in the health care program would make it more accessible. Gardasil was approved on June 8 by the FDA for use in girls and women ages 9 to 26 years. Gardasil is the world's first and only vaccine available for the prevention of cervical cancer.
The program is government subsidized and covers uninsured or poor schoolchildren up to age 18.
Merck has also initiated a new patient assistance program for vaccines. Through this new program, currently available in private physicians' offices, Merck is making available, free of charge, Gardasil and other Merck vaccines indicated for use in individuals aged 19 and older who are uninsured and who are unable to afford vaccines.
Health insurers covering approximately 94% of privately insured lives in the US have decided to reimburse Gardasil. Many lives not covered by Managed Care will now be covered under the Vaccines for Children program.
At the June 2006 meeting of the Advisory Committee for Immunization Practices, the committee voted unanimously to recommend Gardasil to the program.
Source: Datamonitor
Related Articles
- Federal Advisory Committee Votes to Include Newly Licensed Pentacel(R) Vaccine in Vaccines for Children Program
- Analysis: Merck's Vaccine on Solid Ground
- Iomai Chief Scientific Officer Dr. Gregory Glenn to Detail Flu Vaccine Program Today at 'Influenza Vaccines for the World' Conference in Austria
- US FDA approves Merck vaccine to prevent shingles
- CORRECTED: FDA approves Merck vaccine to prevent shingles
- FDA Approval of Merck Vaccine Delayed
- The Long Research Road to a New Vaccine: Rotavirus Vaccine Will Protect Children Against a Major Killer Worldwide
- A Company Review of Merck & Co, Covering, for Example, Their Current Status and Future Outlook
- FDA OKs Merck vaccine for 4 childhood diseases
- FDA Approves PROQUAD(R), the First and Only Vaccine in the U.S. To Help Protect Children Against Measles, Mumps, Rubella and Chickenpox in One Shot; PROQUAD(R) Combines Two Well-Established Merck Vaccines, M-M-R(R)II and VARIVAX(R)
 |
 |
User Comments (0)
RSS Feeds